{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "10/30/2026",
      "update_type": "New",
      "initial_posting_date": "10/30/2026",
      "package_ndc": "66758-087-70",
      "generic_name": "Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops",
      "contact_info": "800-525-8747",
      "related_info": "Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70",
      "openfda": {
        "application_number": [
          "NDA020805"
        ],
        "brand_name": [
          "CIPRO HC"
        ],
        "generic_name": [
          "CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE"
        ],
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "product_ndc": [
          "66758-087"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "AURICULAR (OTIC)"
        ],
        "substance_name": [
          "CIPROFLOXACIN HYDROCHLORIDE",
          "HYDROCORTISONE"
        ],
        "rxcui": [
          "213320",
          "309305"
        ],
        "spl_id": [
          "7c5775a8-2754-4652-b57a-75bbf32dfbe6"
        ],
        "spl_set_id": [
          "b26594a3-2adf-4954-8be0-5bd6f8de9671"
        ],
        "package_ndc": [
          "66758-087-70"
        ],
        "nui": [
          "N0000175576",
          "N0000175450"
        ],
        "pharm_class_epc": [
          "Corticosteroid [EPC]"
        ],
        "pharm_class_moa": [
          "Corticosteroid Hormone Receptor Agonists [MoA]"
        ],
        "unii": [
          "4BA73M5E37",
          "WI4X0X7BPJ"
        ]
      },
      "update_date": "10/30/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "presentation": "Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)",
      "company_name": "Sandoz Inc.",
      "status": "To Be Discontinued"
    }
  ]
}